Indianapolis, INNCT07024693Now EnrollingIRB Ready

Fuchs Endothelial Corneal Dystrophy Clinical Trial in Indianapolis, IN

Access cutting-edge fuchs endothelial corneal dystrophy treatment through this clinical trial at a research site in Indianapolis. Study-provided care at no cost to qualified participants.

Sponsored by Design Therapeutics, Inc.

Quick Self-Assessment

See if you qualify for this Indianapolis location

Preparing your pre-screening questions...

Expert Care in Indianapolis

Access fuchs endothelial corneal dystrophy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related fuchs endothelial corneal dystrophy treatment provided free

Apply for This Indianapolis Location

Check if you qualify for this fuchs endothelial corneal dystrophy clinical trial in Indianapolis, IN

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Indianapolis

    Convenient for IN residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Indianapolis site if eligible
  4. 4Begin participation

About This Fuchs Endothelial Corneal Dystrophy Study in Indianapolis

The purpose of this study is to evaluate the pharmacodynamics, safety, and tolerability of DT-168 Ophthalmic Solution in pre-keratoplasty patients with Fuchs endothelial corneal dystrophy.

Sponsor: Design Therapeutics, Inc.

Who Can Participate

Inclusion Criteria

Participant is scheduled to undergo a keratoplasty for management of FECD independent of this study.
≥30 years of age (inclusive).
Documented diagnosis of FECD in the study eligible eye.
Confirmation of positive TCF4 allele 18.1 CTG expansion in at least one allele.
Capable of giving signed informed consent.

Exclusion Criteria

Any ocular or medical condition in the study eligible eye which is clinically significant or would confound study results or data interpretation.
Any clinically significant medical, nonmedical, and psychiatric disorders that could put the participant at higher risk for participation in the study, impair the participant's ability to participate in the study, or interfere with interpretation of the participant's study results, in the opinion of the investigator.
Concurrent or anticipated need for treatment for FECD, eg, Muro 128 (2% or 5%) during the course of the study in the study eye. Provided the subject undergoes a washo

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Indianapolis?

Yes, this clinical trial (NCT07024693) has an active research site in Indianapolis, IN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Fuchs Endothelial Corneal Dystrophy Treatment Options in Indianapolis, IN

If you're searching for fuchs endothelial corneal dystrophy treatment options in Indianapolis, IN, this clinical trial (NCT07024693) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Indianapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced fuchs endothelial corneal dystrophy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all fuchs endothelial corneal dystrophy clinical trials near you to find additional studies recruiting in your area.

More Ulcerative Colitis Trials in Indianapolis, IN

See all ulcerative colitis clinical trials recruiting in Indianapolis — not just this study.

Browse Ulcerative Colitis Trials in Indianapolis →

Browse More Trials by Condition

Ulcerative Colitis TrialsPulmonary Hypertension TrialsHidradenitis Suppurativa TrialsAll Conditions →

Ready to Join in Indianapolis?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Indianapolis, IN